Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis

Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation

(2014) Lorena Riol-Blanco et al.   NATURE

Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study

(2013) Deepak MW Balak et al.   BMC Neurology

Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis

(2013) Ruth Dobson et al.   JOURNAL OF NEUROLOGY

Janus-like effects of type I interferon in autoimmune diseases

(2012) Robert C. Axtell et al.   IMMUNOLOGICAL REVIEWS

Lobular panniculitis and lipoatrophy of the thighs with interferon-ß1a for intramuscular injection in a patient with multiple sclerosis

(2012) Gesa Weise et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Cutaneous adverse events associated with disease-modifying treatment in multiple sclerosis: a systematic review

(2012) Deepak MW Balak et al.   Multiple Sclerosis Journal

Sarcoidosis Triggered by Interferon-Beta Treatment of Multiple Sclerosis: A Case Report and Focused Literature Review

(2012) Soumya D. Chakravarty et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells

(2011) Kamran Ghoreschi et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Interferon-β exacerbates Th17-mediated inflammatory disease

(2011) Robert C. Axtell et al.   TRENDS IN IMMUNOLOGY

Interferon-α accelerates murine systemic lupus erythematosus in a T cell-dependent manner

(2010) Zheng Liu et al.   ARTHRITIS AND RHEUMATISM

Patient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb study

(2010) Virginia Devonshire et al.   BMC Neurology

Cutaneous reactions following subcutaneous β-interferon-1b injection

(2010) Utako OHATA et al.   JOURNAL OF DERMATOLOGY

New-onset psoriasis in a patient treated with interferon beta-1a

(2009) I. López-Lerma et al.   BRITISH JOURNAL OF DERMATOLOGY

Vitiligo and multiple sclerosis in a patient treated with interferon beta-1a: a case report

(2009) B. Kocer et al.   EUROPEAN JOURNAL OF NEUROLOGY

Psoriasis during interferon beta treatment for multiple sclerosis

(2009) Loredana La Mantia et al.   NEUROLOGICAL SCIENCES

Interferon-  mechanisms of action in multiple sclerosis

(2009) S. Dhib-Jalbut et al.   NEUROLOGY

Sclerosing skin disorders in association with multiple sclerosis. Coincidence, underlying autoimmune pathology or interferon induced?

(2008) T Hugle et al.   ANNALS OF THE RHEUMATIC DISEASES

Severe Dermatomyositis Triggered by Interferon Beta-1a Therapy and Associated With Enhanced Type I Interferon Signaling

(2008) Ally-Khan Somani et al.   ARCHIVES OF DERMATOLOGY

Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark

(2008) NM Nielsen et al.   Multiple Sclerosis Journal